349 Highly potent tumor-targeting optimally primed natural killer cells produced under a feeder-cell free condition in a 50L-scale bioreactor with cytokine-fusion proteins elicits robust anti-tumor response in preclinical study
Ko, Dongwoo, Jae Chan Park, Min-Kyong Hyon, Park, Young Hyun, Gil-Jung, Kim, Ku, Jong Beom, Eom, Iseul, Su Bin Lee, Jeong Mi Yun, Park, Dan Bee, Kim, Do Yeon, Jang, HyeHyeon, Lim, Sora, Jang, Do Soo, Sung Yoo Cho, Hong, Chun Pyo, Myung Ho Jang
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article